Innovent and Takeda Finalize Global Immuno-Oncology Partnership
Innovent Biologics announced that the global strategic collaboration with Takeda has closed and become effective following the satisfaction of all closing conditions. The collaboration, initially announced on October 22, 2025, aims to accelerate the global development and commercialization of Innovent's next-generatio…
